SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

BioNxt Solutions Inc. (BNXTF) News

Follow BioNxt Solutions Inc. (BNXTF) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol BNXTF Asset equity Sector Markets 90 days 2 Last 0.1737 Updated Oct 19, 2026, 07:05 AM UTC Open live news feed Open BNXTF chart & news
L BioNxt Completes GMP Manufacturing, Submits Clinical Trial Application BioNxt completed GMP manufacturing and submitted a clinical trial application for its sublingual cladribine drug candidate. EQUITY | Oct 19, 2026, 07:05 AM UTC L BioNxt advances sublingual everolimus ODF; large-animal PK study begins BioNxt is advancing its sublingual everolimus ODF for organ transplant rejection and has initiated a large-animal pharmacokinetic study. EQUITY | Sep 08, 2026, 07:05 AM UTC L BioNxt Solutions closes convertible debenture extension; issues warrants BioNxt Solutions Inc. announces the closing of an extension of convertible debentures and the issuance of warrants, according to TradeXchange Newsdesk. MNA | Aug 21, 2026, 10:30 PM UTC L BioNxt provides development and IP update across sublingual pipeline BioNxt (BNXTF) issues a development, intellectual property, and commercial update across its sublingual drug delivery pipeline. EQUITY | Aug 17, 2026, 10:40 AM UTC M BioNxt Updates Sublingual Drug Pipeline BioNxt provides development update EQUITY | Aug 04, 2026, 07:05 AM UTC L BioNxt Solutions Announces Option Grants BioNxt Solutions grants options EQUITY | Jul 31, 2026, 10:26 PM UTC L BioNxt Advances GLP-1 Sublingual Semaglutide ODF Program with Next Stage of Delivery Development Underway VANCOUVER, BC / / July 6, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:B EQUITY | Jul 06, 2026, 07:05 AM UTC L BNXT: Closes Private Placement BioNxt announces closing of non-brokered private placement of units EQUITY | Jun 23, 2026, 09:20 PM UTC